Scinomed Ltd - Accounts to registrar (filleted) - small 22.3
Scinomed Ltd - Accounts to registrar (filleted) - small 22.3
REGISTERED NUMBER: |
SCINOMED LTD |
FINANCIAL STATEMENTS |
FOR THE PERIOD |
1 JANUARY 2021 TO 29 DECEMBER 2021 |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 4 |
SCINOMED LTD |
COMPANY INFORMATION |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
AUDITORS: |
Chartered Accountants |
Statutory Auditors |
Tattersall House |
East Parade |
Harrogate |
North Yorkshire |
HG1 5LT |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
BALANCE SHEET |
29 DECEMBER 2021 |
2021 | 2020 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Intangible assets | 4 |
Tangible assets | 5 |
Investments | 6 |
CURRENT ASSETS |
Stocks |
Debtors | 7 |
Prepayments and accrued income |
Cash at bank and in hand |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year | 9 | ( |
) | ( |
) |
ACCRUALS AND DEFERRED INCOME | ( |
) | ( |
) |
NET LIABILITIES | ( |
) | ( |
) |
CAPITAL AND RESERVES |
Called up share capital |
Share premium |
Retained earnings | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
BALANCE SHEET - continued |
29 DECEMBER 2021 |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
1. | STATUTORY INFORMATION |
Scinomed Ltd is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Preparation of consolidated financial statements |
The financial statements contain information about Scinomed Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements. |
Going concern |
At the balance sheet date, the company had net liabilities of £7,893,091. |
The parent undertaking and ultimate parent undertaking have confirmed that they will provide further financial support to the company as required to enable it to meet its liabilities as and when they fall due for at least twelve months from the date of approval of the financial statements of the company. Consequently, the financial statements have been prepared on a going concern basis. |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
Intangible assets |
Amortisation is provided at the following annual rate in order to write off each asset over its estimated useful life. |
Intellectual Property - 25% on cost |
Research & development costs |
Where research and development costs are capitalised, amortisation is provided at the following annual rate in order to write off each asset over its estimated useful life. |
Research and development costs - between 10% and 20% on cost |
Tangible fixed assets |
Improvements to property | - |
Plant and machinery | - |
Fixtures and fittings | - |
Office Equipment | - |
Investments in subsidiaries |
Investments in subsidiary undertakings are recognised at cost. |
Stocks |
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
2. | ACCOUNTING POLICIES - continued |
Taxation |
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the period was |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
4. | INTANGIBLE FIXED ASSETS |
Other |
intangible |
assets |
£ |
COST |
At 1 January 2021 |
Additions |
Disposals | ( |
) |
At 29 December 2021 |
AMORTISATION |
At 1 January 2021 |
Charge for period |
Eliminated on disposal | ( |
) |
At 29 December 2021 |
NET BOOK VALUE |
At 29 December 2021 |
At 31 December 2020 |
5. | TANGIBLE FIXED ASSETS |
Improvements | Fixtures |
to | Plant and | and | Office |
property | machinery | fittings | Equipment | Totals |
£ | £ | £ | £ | £ |
COST |
At 1 January 2021 |
Additions |
Disposals | ( |
) | ( |
) |
At 29 December 2021 |
DEPRECIATION |
At 1 January 2021 |
Charge for period |
Eliminated on disposal | ( |
) | ( |
) |
At 29 December 2021 |
NET BOOK VALUE |
At 29 December 2021 |
At 31 December 2020 |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
6. | FIXED ASSET INVESTMENTS |
Shares in | Interest |
group | in joint |
undertakings | venture | Totals |
£ | £ | £ |
COST |
At 1 January 2021 |
and 29 December 2021 | 1,812,845 |
NET BOOK VALUE |
At 29 December 2021 | 1,812,845 |
At 31 December 2020 | 1,812,845 |
7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2021 | 2020 |
£ | £ |
Trade debtors |
Amounts owed by group undertakings |
Other debtors |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2021 | 2020 |
£ | £ |
Trade creditors |
Taxation and social security |
Other creditors |
9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
2021 | 2020 |
£ | £ |
Amounts owed to group undertakings |
The loans are unsecured with no set repayment date. A market rate of interest is payable on the loans. |
SCINOMED LTD (REGISTERED NUMBER: 06509477) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2021 TO 29 DECEMBER 2021 |
10. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
The Report of the Auditors was qualified on the following basis: |
Basis for qualified opinion |
We were not appointed as auditor of the company until after 31 December 2020 and thus did not observe the counting of physical inventories at the end of the year. We were unable to satisfy ourselves by alternative means concerning the inventory quantities held at 31 December 2020, which are included in the balance sheet at £1,122,529, by using other audit procedures. Consequently, we were unable to determine whether any adjustment to this amount was necessary. |
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our | responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial | statements section of our report. We are independent of the company in accordance with the ethical requirements that are | relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other | ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient | and appropriate to provide a basis for our qualified opinion. |
Matters required to report by exception |
Arising solely from the limitations on the scope of our work relating to inventory, referred to above: |
- we have not obtained all the information and explanations that we considered necessary for the purpose of our audit. |
We have nothing to report in respect of the following matters where the Companies Act requires us to report to you if, in our opinion: |
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
- the financial statements are not in agreement with the accounting records and returns; or |
- certain disclosures of directors' remuneration specified by law are not made. |
- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors. |
for and on behalf of |
11. | POST BALANCE SHEET EVENTS |
In 2022 the company acquired the remaining 50% in its Chinese Joint Venture, Scinomed (Shanghai) Bio-Tech Co. Ltd. The company is now a 100% subsidiary of Scinomed Limited. |
12. | ULTIMATE CONTROLLING PARTY |
The controlling party is International Investments II Limited, a company incorporated in Hong Kong. |